Effect of airborne hydrogen peroxide on spores of Clostridium difficile;Effekt von gasförmigem Wasserstoffperoxid auf Sporen von Clostridium difficile

Wiener Klinische Wochenschrift

Volumn 127, Issue 11-12, 2015, Pages 421-426

  Steindl, Georg ^a   Fiedler, Anita ^a   Huhulescu, Steliana ^a   Wewalka, Günther ^a   Allerberger, Franz ^a  

^a AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

Author keywords

Airborne hydrogen peroxide; C. difficile; Decontamination; Spores; Surface

Indexed keywords

BOVINE SERUM ALBUMIN; HYDROGEN PEROXIDE; AEROSOL;

AEROSOL; AIRBORNE PARTICLE; ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL SPORE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM CONTAMINATION; CONTROLLED STUDY; DISINFECTION; FUMIGATION; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; SHEEP ERYTHROCYTE; AIR; CELL PROLIFERATION; CELL SURVIVAL; DEVICES; DRUG EFFECTS; EQUIPMENT CONTAMINATION; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PHARMACOLOGY; PHYSIOLOGY; PROCEDURES;

AEROSOLS; AIR; CELL PROLIFERATION; CELL SURVIVAL; CLOSTRIDIUM DIFFICILE; DISINFECTION; EQUIPMENT AND SUPPLIES; EQUIPMENT CONTAMINATION; HYDROGEN PEROXIDE; SPORES, BACTERIAL;

EID: 84933679724     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-014-0682-6     Document Type: Article

References (23)

1. Schmid D, Kuo HW, Simons E, Wenisch J, Allerberger F, Wenisch C. All-cause mortality in hospitalized patients with infectious diarrhea: Clostridium difficile versus other enteric pathogens in Austria from 2008 to 2010. J Infect Public Health. 2014;7(2):133–44.
2. McGowan AP, Lalayiannis LC, Sarma JB, et al. Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Trust between 2002 and 2008. J Hosp Infect. 2011;77(1):11–5.
3. Debast SB, Bauer MP, Kuijper EJ, European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(Suppl. 2):1–26.
4. Bouza E. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect. 2012;18(Suppl. 6):5–12.
5. Rutala WA, Weber DJ. Are room decontamination units needed to prevent transmission of environmental pathogens? Inf Control Hosp Epidemiol. 2011;32(8):743–7.
6. Kuijper EJ, Coignart B, Tüll P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12(Suppl. 6):2–18.
7. Merrigan M, Venugopal A, Mallozzi M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol. 2010;192(19):4904–11.
8. Indra A, Huhulescu S, Fiedler A, et al. Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008–2009. Euro Surveill. 2009;14(17):pii=19186.
9. Otter JA, Yezli S, French GL. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol. 2011;32(7):687–99.
10. Otter JA, French GL. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J Clin Microbiol. 2009;27(1):205–7.
11. Donskey CJ. Preventing transmission of Clostridium difficile: is the answer blowing in the wind? Clin Infect Dis. 2010;50(11):1458–61.
12. Maillard JY. Innate resistance to sporicides and potential failure to decontaminate. J Hosp Infect. 2011;77(3):204–9.
13. Otter JA, Yezli S, Perl TM, et al. The role of ‘no-touch’ automated room disinfection systems in infection prevention and control. J Hosp Infect. 2013;83(1):1–13.
14. Andersen BM, Rasch M, Hochlin K. Decontamination of rooms, medical equipment and ambulances using an aerosol of hydrogen peroxide disinfectant. J Hosp Infect. 2006;62(2):149–55.
15. Finnegan M, Denyer SP, McDonnell G, et al. Mode of action of hydrogen peroxide and other oxidizing agents: differences between liquid and gas forms. J Antimicrob Chemother. 2010;65(10):2108–15.
16. Bereket W, Hemalatha K, Getenet B, et al. Update on bacterial nosocomial infections. Eur Rev Med Pharmacol Sci. 2012;16(8):1039–44.
17. Stiefel U, Cadnum JL, Eckstein BC, et al. Contamination of hands with methicillin-resistant Staphylococcus aureus after contact with environmental surfaces and after contact with the skin of colonized patients. Infect Control Hosp Epidemiol. 2011;32(2):185–7.
18. Falagas ME, Thomaidis PC, Kotsantis IK, et al. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect. 2011;78(3):171–7.
19. Walder M, Holmdahl T. Reply to Roberts. Infect Control Hosp Epidemiol. 2012;33(3):312–3.
20. Shapey S, Machin K, Levi K, et al. Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards. J Hosp Infect. 2008;70(2):136–41.
21. Barbut F, Menuet D, Verachten M, et al. Comparison of the efficacy of a hydrogen peroxide dry mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol. 2009;30(6):507–14.
22. Havill NL, Moore BA, Boyce JM. Comparison of the microbiological efficacy of hydrogen peroxide vapor and ultraviolet light processes for room decontamination. Infect Control Hosp Epidemiol. 2012;33(5):507–12.
23. Barbut F, Yezli S, Otter JA. Activity in vitro of hydrogen peroxide vapour against Clostridium difficile spores. J Hosp Infect. 2012;80(1):85–7.